Clinical Trial Update: Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating fecal microbiota transplantation with FMP30 for relapsing-remitting multiple sclerosis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• FMP30

Snippet

Sponsor: Jeffrey Gelfand | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 1 | Status: TERMINATED | Results posted: 2026-02-03